Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders

Rodrigo Barros, Gabriel Moreira Crelier, Luciano Alves Favorito

Open source

DOI
10.1097/mou.0000000000001438
Published
2026-07-28
Container
Current Opinion in Urology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mou.0000000000001438,
  title = {Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders},
  author = {Rodrigo Barros and Gabriel Moreira Crelier and Luciano Alves Favorito},
  year = {2026},
  journal = {Current Opinion in Urology},
  doi = {10.1097/mou.0000000000001438},
  url = {https://doi.org/10.1097/mou.0000000000001438}
}

RIS

TY  - JOUR
TI  - Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders
AU  - Rodrigo Barros
AU  - Gabriel Moreira Crelier
AU  - Luciano Alves Favorito
PY  - 2026
JO  - Current Opinion in Urology
DO  - 10.1097/mou.0000000000001438
UR  - https://doi.org/10.1097/mou.0000000000001438
ER  - 

APA

Barros, R., Crelier, G. M., & Favorito, L. A. (2026). Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders. Current Opinion in Urology. https://doi.org/10.1097/mou.0000000000001438

Source records